Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-10-036817
Filing Date
2010-07-06
Accepted
2010-07-06 21:17:29
Documents
1
Period of Report
2010-07-01

Document Format Files

Seq Description Document Type Size
1 form433538_070610211712-.html 4  
1 form433538_070610211712-.xml 4 3512
  Complete submission text file 0001144204-10-036817.txt   5260
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O OXIGENE, INC., 230 THIRD AVENUE WALTHAM MA 02451
Business Address
Schwieterman William D (Reporting) CIK: 0001403961 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 10940857